CASTLE BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable
CASTLE BIOSCIENCES, INC. (CSTL) reported Increase (Decrease) in Accounts Payable of $886.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$2.31M, a 314.80% decline year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $3.19M, a 419.19% increase year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$17.00K.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.41M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2025 was $3.08M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2024 was -$4.37M, a 176.61% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2023 was $5.71M, a 880.58% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2022 was $582.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $886.00K 10-Q · filed 2026-07-30 | $869.00K derived: sum of 3 quarters · filed 2026-07-30 | $2.27M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $3.19M 10-Q · filed 2026-05-06 | $3.18M derived: sum of 2 quarters · filed 2026-05-06 | $4.58M derived: sum of 3 quarters · filed 2026-05-06 | $5.66M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.39M derived: sum of 2 quarters · filed 2026-02-26 | $2.46M derived: sum of 3 quarters · filed 2026-07-30 | $3.08M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $2.48M derived: sum of 2 quarters · filed 2026-07-30 | $3.10M 10-Q · filed 2025-11-03 | $2.52M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.69M 10-Q · filed 2026-07-30 | $1.12M derived: sum of 3 quarters · filed 2026-07-30 | -$1.03M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $615.00K 10-Q · filed 2026-05-06 | $45.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.11M derived: sum of 3 quarters · filed 2026-05-06 | -$3.33M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.72M derived: sum of 2 quarters · filed 2026-02-26 | -$3.95M derived: sum of 3 quarters · filed 2026-02-26 | -$4.37M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$3.38M derived: sum of 2 quarters · filed 2025-11-03 | -$3.80M 10-Q · filed 2025-11-03 | -$788.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$1.65M 10-Q · filed 2025-08-04 | $1.36M derived: sum of 3 quarters · filed 2026-02-26 | $986.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$422.00K 10-Q · filed 2025-05-05 | $2.59M derived: sum of 2 quarters · filed 2026-02-26 | $2.21M derived: sum of 3 quarters · filed 2026-02-26 | $1.39M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.64M derived: sum of 2 quarters · filed 2026-02-26 | $1.81M derived: sum of 3 quarters · filed 2026-02-26 | $5.71M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$1.20M derived: sum of 2 quarters · filed 2024-11-04 | $2.69M 10-Q · filed 2024-11-04 | $1.12M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$825.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $3.07M 10-Q · filed 2024-08-05 | $1.50M derived: sum of 3 quarters · filed 2025-02-27 | $3.35M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $3.90M 10-Q · filed 2024-05-02 | $2.32M derived: sum of 2 quarters · filed 2025-02-27 | $4.18M derived: sum of 3 quarters · filed 2025-02-27 | $4.29M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $280.00K derived: sum of 2 quarters · filed 2025-02-27 | $395.00K derived: sum of 3 quarters · filed 2025-02-27 | $582.00K 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.97M derived: sum of 2 quarters · filed 2023-11-02 | $2.15M 10-Q · filed 2023-11-02 | $1.30M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $302.00K 10-Q · filed 2023-08-02 | -$553.00K derived: sum of 3 quarters · filed 2023-08-02 | $803.00K derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $187.00K 10-Q · filed 2023-05-03 | -$668.00K derived: sum of 2 quarters · filed 2023-05-03 | $688.00K derived: sum of 3 quarters · filed 2023-05-03 | $45.00K derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | -$855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $501.00K derived: sum of 2 quarters · filed 2023-02-28 | -$142.00K derived: sum of 3 quarters · filed 2023-02-28 | -$182.00K 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $713.00K derived: sum of 2 quarters · filed 2022-11-02 | $673.00K 10-Q · filed 2022-11-02 | $631.00K derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | -$643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$683.00K 10-Q · filed 2022-08-08 | -$725.00K derived: sum of 3 quarters · filed 2022-08-08 | -$958.00K derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$40.00K 10-Q · filed 2022-05-09 | -$82.00K derived: sum of 2 quarters · filed 2022-05-09 | -$315.00K derived: sum of 3 quarters · filed 2022-05-09 | $73.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$275.00K derived: sum of 2 quarters · filed 2022-02-28 | $113.00K derived: sum of 3 quarters · filed 2022-02-28 | $169.00K 10-K · filed 2022-02-28 | ||
| 2020-09-30 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $155.00K derived: sum of 2 quarters · filed 2021-11-08 | $211.00K 10-Q · filed 2021-11-08 | $815.00K derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $388.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $444.00K 10-Q · filed 2021-08-09 | $1.05M derived: sum of 3 quarters · filed 2021-08-09 | $1.52M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $56.00K 10-Q · filed 2021-05-10 | $660.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.14M derived: sum of 3 quarters · filed 2021-05-10 | $942.00K derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.08M derived: sum of 2 quarters · filed 2021-03-11 | $886.00K derived: sum of 3 quarters · filed 2021-03-11 | $557.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $477.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $282.00K derived: sum of 2 quarters · filed 2020-11-09 | -$47.00K 10-Q · filed 2020-11-09 | -$46.93K 10-Q · filed 2019-11-12 | $320.89K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$524.00K 10-Q · filed 2020-08-10 | -$524.03K 10-Q · filed 2019-09-03 | -$156.11K derived: sum of 3 quarters · filed 2020-08-10 | $280.68K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$329.00K 10-Q · filed 2020-05-11 | $38.89K derived: sum of 2 quarters · filed 2020-05-11 | $475.68K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $367.89K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $804.68K derived: sum of 2 quarters · filed 2020-03-10 | $197.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $436.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$170.89K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$607.68K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |